Results

Total Results: 463 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

21. Adolescent Diabetes: A Routine Visit? | PSNet
    psnet.ahrq.gov/web-mm/adolescent-diabetes-routine-visit
    November 18, 2016 - or gestational diabetes. … diet, exercise, and glucose monitoring should begin at diagnosis for all patients and may be the only therapy … the case presentation, is available only for subcutaneous administration; is indicated for adjunctive therapy … She also complained that her acne had worsened, and she requested treatment for it. … American Diabetes Association. Standards of medical care in diabetes—2009.

22. Too Tight Control | PSNet
    psnet.ahrq.gov/web-mm/too-tight-control
    March 20, 2013 - More recently, intensive IV insulin therapy is being used in post-surgical patients for whom diabetes … Secondly, clinicians may administer therapies to patients who would have been excluded from trials.( … , or unnecessary treatment. … Intensive insulin therapy in the critically ill patients. … Infection and diabetes: the case for glucose control.

23. Artificial intelligence will improve medical treatments. | PSNet
    psnet.ahrq.gov/issue/artificial-intelligence-will-improve-medical-treatments
    February 06, 2019 - Newspaper/Magazine Article Artificial intelligence will improve medical treatments … Citation Text: Artificial intelligence will improve medical treatments. The Economist. … Smart technology, safety and therapeutic relationships. … July 12, 2017 The challenges of electronic health records and diabetes electronic prescribing … Information Professionals Medicine Epidemiology of Errors and Adverse Events Computer-Assisted Therapy

24. One ACE Too Many | PSNet
    psnet.ahrq.gov/web-mm/one-ace-too-many
    June 21, 2016 - The Case A 72-year-old man with coronary artery disease, diabetes, and recently diagnosed congestive … heavily influenced by multiple factors, including the dose of the offending drug(s), use of concomitant therapies … A patient with left ventricular systolic dysfunction and diabetes who is receiving a maximal dose of … The obvious downsides of this approach are the delay to treatment and the possibility that the therapy … Diabetes may be independent risk factor for hyperkalaemia. BMJ. 2003;327:812. [go to PubMed] 4.

25. Dropping to New Lows | PSNet
    psnet.ahrq.gov/web-mm/dropping-new-lows
    December 18, 2024 - oral diabetes agents and other non-insulin therapies in most circumstances. … acute renal failure, and receipt of IV contrast.( 3 ) In most instances, insulin is the preferred treatment … Association inpatient glycemic control guidelines were revised to initiate insulin therapy for persistent … to keep target glucose in the controlled, rather than tight, range.( 3 ) Specifically, once insulin therapy … Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.

26. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/35620/psn-pdf
    February 03, 2011 - Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute … Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute … https://psnet.ahrq.gov/issue/excess-dosing-antiplatelet-and-antithrombin-agents-treatment-non-st-segment … - elevation-acute Treatment of acute coronary syndromes (ACS) benefits from extensive research outlining … seem directed at vulnerable populations such as elderly patients with specific comorbidities (eg, diabetes

27. Spotlight Case [MONTH] 2003 (ppt file)
    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.60_slideshow.ppt
    May 01, 2004 - results of clinical trials Case: Too Much of a Good Thing A 28-year-old man with insulin-dependent diabetes … Infection and diabetes: the case for glucose control. … Quality Improvement Measure Most quality improvement efforts focused on the “underuse” of effective therapies … Conventional Treatment (%) Intensive Treatment (%) > 14 days ICU 15.7% 11.4% > 14 days ventilator … (%) Intensive Treatment (%)

28. A Sweet Case of Hidden Hydrogen Ions | PSNet
    psnet.ahrq.gov/web-mm/sweet-case-hidden-hydrogen-ions
    November 30, 2023 - combination of high AG metabolic acidosis from DKA and metabolic alkalosis from vomiting, then appropriate treatment … automating the consultation process, would be expected to reduce delays in diagnosis and effective treatment … continuing medical education (CME) that coincide with CDS tools and order sets on physiologic insulin therapy … Focus on Insulin Therapy and Hypoglycemia. Published February 1, 2018. … Available at:  https://glytecsystems.com/resource/u-s-survey-of-healthcare-professionals-inpatient-diabetes-care-and-glycemic-management-focus-on-insulin-therapy-and-hypoglycemia

29. Prolonged DKA in Pregnancy: A Case of Communication Breakdown. | PSNet
    psnet.ahrq.gov/web-mm/prolonged-dka-pregnancy-case-communication-breakdown
    June 28, 2023 - replacement with intravenous fluid, correction of electrolyte abnormalities, and intravenous insulin therapy … multidisciplinary, bringing together professionals from different fields to determine and deliver patients’ treatment … a BUN-to-creatinine ration of 15 Background : She is 6 weeks pregnant and in DKA Assessment : Oral therapy … Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. … September 6, 2017 Teamwork is associated with reduced hospital staff burnout at military treatment

30. Spotlight Case July 2008 (ppt file)
    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.212_slideshow.ppt
    February 01, 2010 - Type 2 Diabetes in Adolescents Type 2 diabetes mellitus (T2DM) in adolescents is also increasing T2DM … diabetes mellitus in youth. … or gestational diabetes American Diabetes Association. … She complained that her acne had worsened and requested treatment for it. … adolescence and is associated with a two-fold increased risk of pregnancy Adherence to Treatment

31. Inpatient Stroke Management in an Adolescent with Type 1 Diabetes and Home Insulin Pump | PSNet
    psnet.ahrq.gov/web-mm/inpatient-stroke-management-adolescent-type-1-diabetes-and-home-insulin-pump
    February 01, 2023 - Imaging identified a new MCA territory infarct, and enoxaparin treatment was initiated. … Contraindications to insulin pump therapy – including critical illness, prolonged surgical procedures … If pump therapy is continued, consultation with an endocrinologist and/or diabetes education specialist … Diabetes technology & therapeutics 2019;21:66-72.  Munt R, Hutton A. … Diabetes technology & therapeutics 2017;19:363-9.  American Diabetes A. 15.

32. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/73200/psn-pdf
    April 28, 2021 - combination of high AG metabolic acidosis from DKA and metabolic alkalosis from vomiting, then appropriate treatment … automating the consultation process, would be expected to reduce delays in diagnosis and effective treatment … Focus on Insulin Therapy and Hypoglycemia. Published February 1, 2018. … - care-and-glycemic-management-focus-on-insulin-therapy-and-hypoglycemia/.  … / https://glytecsystems.com/resource/u-s-survey-of-healthcare-professionals-inpatient-diabetes-care-and-glycemic-management-focus-on-insulin-therapy-and-hypoglycemia

33. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49758/psn-pdf
    April 01, 2016 - oral diabetes agents and other non-insulin therapies in most circumstances. … , acute renal failure, and receipt of IV contrast.(3) In most instances, insulin is the preferred treatment … Association inpatient glycemic control guidelines were revised to initiate insulin therapy for persistent … to keep target glucose in the controlled, rather than tight, range.(3) Specifically, once insulin therapy … Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.

34. Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment elevation acute coronary syndromes. | PSNet
    psnet.ahrq.gov/issue/excess-dosing-antiplatelet-and-antithrombin-agents-treatment-non-st-segment-elevation-acute
    November 10, 2015 - Study Excess dosing of antiplatelet and antithrombin agents in the treatment of non–ST-segment … Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute … Treatment of acute coronary syndromes (ACS) benefits from extensive research outlining evidence-based … also seem directed at vulnerable populations such as elderly patients with specific comorbidities (eg, diabetes … November 17, 2011 Relationship of incorrect dosing of fibrinolytic therapy and clinical

35. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49704/psn-pdf
    March 01, 2014 - These therapies were given to prevent the need for a more risky exchange transfusion. … The patient improved and he ultimately did well with appropriate therapies. … , blood tests, and treatments is challenging. … Perinatal risk factors for childhood type 1 diabetes in Europe. … Diabetes Care. 2003;26:247-248. [go to PubMed] 14.

36. Diagnosing a Missed Diagnosis | PSNet
    psnet.ahrq.gov/web-mm/diagnosing-missed-diagnosis
    October 26, 2022 - Her lithium was discontinued and she was started on valproic acid for treatment of her bipolar disorder … Reilly, MD, MS, and Christopher Webster, DO Long-term lithium use for treatment of bipolar or mood … Nephrogenic diabetes insipidus. Ann Intern Med. 2006;144:186-194. [go to PubMed] 5. … Causes of reversible nephrogenic diabetes insipidus: a systematic review. … creating cognitive challenges that are not required at the time (e.g., planning alternative diagnosis/treatment

37. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. | PSNet
    psnet.ahrq.gov/issue/antibiotic-resistant-infection-treatment-costs-have-doubled-2002-now-exceeding-2-billion
    July 02, 2019 - Study Classic Antibiotic-resistant infection treatment … Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually … increasingly common in hospitals and ambulatory care, primarily driven by overuse of antibiotics for treatment … Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually … Related Resources Potentially inappropriate prescribing for adults living with diabetes

38. Leaving patients to their own devices? Smart technology, safety and therapeutic relationships. | PSNet
    psnet.ahrq.gov/issue/leaving-patients-their-own-devices-smart-technology-safety-and-therapeutic-relationships
    December 04, 2024 - Smart technology, safety and therapeutic relationships. … Smart technology, safety and therapeutic relationships. … January 15, 2025 Type 1 diabetes defined by severe insulin deficiency occurs after 30 … years of age and is commonly treated as type 2 diabetes. … July 11, 2018 Artificial intelligence will improve medical treatments.

39. Misadministration of IV insulin associated with dose measurement and hyperkalemia treatment. | PSNet
    psnet.ahrq.gov/issue/misadministration-iv-insulin-associated-dose-measurement-and-hyperkalemia-treatment
    August 24, 2016 - Misadministration of IV insulin associated with dose measurement and hyperkalemia treatment … Citation Text: Misadministration of IV insulin associated with dose measurement and hyperkalemia treatment … Citation Text: Misadministration of IV insulin associated with dose measurement and hyperkalemia treatment … July 6, 2011 Medication errors common for hospital diabetes.

40. Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. | PSNet
    psnet.ahrq.gov/issue/patients-expectations-benefits-and-harms-treatments-screening-and-tests-systematic-review
    September 29, 2017 - Review Patients' expectations of the benefits and harms of treatments, screening, … Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review … March 13, 2024 Potentially inappropriate prescribing for adults living with diabetes … September 29, 2021 To expand the evidence base about harms from tests and treatments. … September 29, 2017 Clinicians' expectations of the benefits and harms of treatments,